Evaluation of serum tumor necrosis factor α and its correlation with histology in chronic kidney disease, stable renal transplant and rejection cases

Tumor necrosis factor alpha (TNF α) is a cytokine secreted by macrophages, helper T cells, Natural Killer cells, B lymphocytes and non lymphoid cells e.g. endothelial cells, fibroblast and tumor cell lines. Aim of the study was to find the utility of TNF α in diagnosing renal trans...

Full description

Bibliographic Details
Main Authors: Sonkar Gyanendra, Usha, Singh R
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2009-01-01
Series:Saudi Journal of Kidney Diseases and Transplantation
Online Access:http://www.sjkdt.org/article.asp?issn=1319-2442;year=2009;volume=20;issue=6;spage=1000;epage=1004;aulast=Sonkar
id doaj-9f294be98309408c950bee2d7ba26375
record_format Article
spelling doaj-9f294be98309408c950bee2d7ba263752020-11-24T23:38:12ZengWolters Kluwer Medknow PublicationsSaudi Journal of Kidney Diseases and Transplantation1319-24422009-01-0120610001004Evaluation of serum tumor necrosis factor α and its correlation with histology in chronic kidney disease, stable renal transplant and rejection casesSonkar GyanendraUshaSingh RTumor necrosis factor alpha (TNF α) is a cytokine secreted by macrophages, helper T cells, Natural Killer cells, B lymphocytes and non lymphoid cells e.g. endothelial cells, fibroblast and tumor cell lines. Aim of the study was to find the utility of TNF α in diagnosing renal transplant rejection among the renal transplant cases (n=29), and comparison with the levels in patients on maintenance hemodialysis (n=21) and healthy controls (n=20). TNF α in healthy controls varied from 2 to 15 pg/mL. In chronic renal failure and renal transplant rejection cases TNF α was above 45 pg/mL. In stable renal transplant patients it was higher than normal (16 to 30 pg/mL). In both acute and chronic transplant rejection TNF α increase correlated well with histology. Thus our study suggests that TNF α level more than 45 pg/mL can be taken as an immunological marker of renal transplant rejection.http://www.sjkdt.org/article.asp?issn=1319-2442;year=2009;volume=20;issue=6;spage=1000;epage=1004;aulast=Sonkar
collection DOAJ
language English
format Article
sources DOAJ
author Sonkar Gyanendra
Usha
Singh R
spellingShingle Sonkar Gyanendra
Usha
Singh R
Evaluation of serum tumor necrosis factor α and its correlation with histology in chronic kidney disease, stable renal transplant and rejection cases
Saudi Journal of Kidney Diseases and Transplantation
author_facet Sonkar Gyanendra
Usha
Singh R
author_sort Sonkar Gyanendra
title Evaluation of serum tumor necrosis factor α and its correlation with histology in chronic kidney disease, stable renal transplant and rejection cases
title_short Evaluation of serum tumor necrosis factor α and its correlation with histology in chronic kidney disease, stable renal transplant and rejection cases
title_full Evaluation of serum tumor necrosis factor α and its correlation with histology in chronic kidney disease, stable renal transplant and rejection cases
title_fullStr Evaluation of serum tumor necrosis factor α and its correlation with histology in chronic kidney disease, stable renal transplant and rejection cases
title_full_unstemmed Evaluation of serum tumor necrosis factor α and its correlation with histology in chronic kidney disease, stable renal transplant and rejection cases
title_sort evaluation of serum tumor necrosis factor α and its correlation with histology in chronic kidney disease, stable renal transplant and rejection cases
publisher Wolters Kluwer Medknow Publications
series Saudi Journal of Kidney Diseases and Transplantation
issn 1319-2442
publishDate 2009-01-01
description Tumor necrosis factor alpha (TNF α) is a cytokine secreted by macrophages, helper T cells, Natural Killer cells, B lymphocytes and non lymphoid cells e.g. endothelial cells, fibroblast and tumor cell lines. Aim of the study was to find the utility of TNF α in diagnosing renal transplant rejection among the renal transplant cases (n=29), and comparison with the levels in patients on maintenance hemodialysis (n=21) and healthy controls (n=20). TNF α in healthy controls varied from 2 to 15 pg/mL. In chronic renal failure and renal transplant rejection cases TNF α was above 45 pg/mL. In stable renal transplant patients it was higher than normal (16 to 30 pg/mL). In both acute and chronic transplant rejection TNF α increase correlated well with histology. Thus our study suggests that TNF α level more than 45 pg/mL can be taken as an immunological marker of renal transplant rejection.
url http://www.sjkdt.org/article.asp?issn=1319-2442;year=2009;volume=20;issue=6;spage=1000;epage=1004;aulast=Sonkar
work_keys_str_mv AT sonkargyanendra evaluationofserumtumornecrosisfactor945anditscorrelationwithhistologyinchronickidneydiseasestablerenaltransplantandrejectioncases
AT usha evaluationofserumtumornecrosisfactor945anditscorrelationwithhistologyinchronickidneydiseasestablerenaltransplantandrejectioncases
AT singhr evaluationofserumtumornecrosisfactor945anditscorrelationwithhistologyinchronickidneydiseasestablerenaltransplantandrejectioncases
_version_ 1725517595924234240